You can go to this link to check short interest in a stock:
http://nasdaqtrader.com/Trader.aspx?id=ShortInterest
Publication schedule is here:
http://nasdaqtrader.com/Trader.aspx?id=ShortIntPubSch
(I like to keep this posted on a stock I follow because NASDAQ only keeps 12 months. If anyone has older data it would be interesting to see)
Settlement Date/Short Interest/Percent Change/Average Daily Share Volume/Days to Cover
Settlement Date Short Interest Percent Change Average Daily Share Volume Days to Cover
06/30/2020 30,244,846 16.05 4,440,585 6.81
06/15/2020 26,061,751 (4.32) 4,444,238 5.86
05/29/2020 27,239,015 2.76 10,723,636 2.54
05/15/2020 26,507,994 23.82 8,097,608 3.27
04/30/2020 21,408,484 (8.34) 5,552,583 3.86
04/15/2020 23,356,262 (7.02) 3,908,466 5.98
03/31/2020 25,118,416 (2.07) 8,103,375 3.10
03/13/2020 25,648,785 7.73 5,206,303 4.93
02/28/2020 23,809,064 (7.08) 8,945,089 2.66
02/14/2020 25,622,422 (0.08) 5,286,567 4.85
01/31/2020 25,642,035 25.93 7,272,759 3.53
01/15/2020 20,362,771 (24.28) 6,731,086 3.03
12/31/2019 26,890,498 0.13 5,435,540 4.95
12/13/2019 26,855,728 (2.10) 17,911,481 1.50
11/29/2019 27,431,603 1.85 16,550,496 1.66
11/15/2019 26,932,138 22.53 12,804,991 2.10
10/31/2019 21,979,837 2.21 3,916,605 5.61
10/15/2019 21,503,874 3.58 3,126,971 6.88
09/30/2019 20,761,101 (6.58) 4,819,292 4.31
09/13/2019 22,223,363 6.11 3,109,896 7.15
08/30/2019 20,943,066 19.86 3,063,310 6.84
08/15/2019 17,473,086 82.03 6,821,417 2.56
07/31/2019 9,599,270 (14.21) 2,124,097 4.52
07/15/2019 11,189,700 7.35 1,579,277 7.0
[/quote]
Recent CLVSQ News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/18/2023 04:15:24 AM
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 07/11/2023 04:09:55 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 07/11/2023 04:05:29 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 07/11/2023 03:43:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2023 01:37:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2023 09:08:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM